138 results on '"Soutullo, César"'
Search Results
2. Measurement invariance of the Screen for Child Anxiety Related Emotional Disorders (SCARED) across ethnicity, age, and sex among youth with depression
3. Clinical correlates of anxious depression in youth from the Texas Youth Depression and Suicide Research Network (TX-YDSRN)
4. The clinical presentation of major depressive disorder in youth with co-occurring obsessive-compulsive disorder
5. Data-driven subgrouping of youths with depression reveals that resilience is associated with higher physical functioning despite high symptom burden in the Texas Youth Depression and Suicide Research Network (TX-YDSRN)
6. The many faces of microbiota-gut-brain axis in autism spectrum disorder
7. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder
8. Texas Youth Depression and Suicide Research Network (TX-YDSRN) research registry and learning healthcare network: Rationale, design, and baseline characteristics
9. Psychometric properties of Concise Associated Symptom Tracking (CAST) scale in youths and young adults: Findings from the Texas youth depression and suicide research network (TX-YDSRN)
10. Anxiety Disorders
11. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder
12. Systematic Review: Medication Effects on Brain Intrinsic Functional Connectivity in Patients With Attention-Deficit/Hyperactivity Disorder
13. Phenomenology and diagnostic stability of paediatric bipolar disorder in a Spanish sample
14. Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: A systematic review and meta-analysis
15. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials
16. Differences in maintenance of response upon discontinuation across medication treatments in attention-deficit/hyperactivity disorder
17. Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
18. Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder
19. Anxiety Disorders
20. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
21. Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder
22. Altered default network resting state functional connectivity in patients with a first episode of psychosis
23. Longitudinal changes in brain structure following the first episode of psychosis
24. Can positive family factors be protective against the development of psychosis?
25. The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
26. Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder
27. 2.42 Development of a Short Version of the ADHD Rating Scale-IV.es (sADHD-RS-IV.es)
28. Cannabis use in children and adolescents with first episode psychosis: Influence on psychopathology and short-term outcome (CAFEPS study)
29. A Post Hoc Comparison of the Effects of Lisdexamfetamine Dimesylate and Osmotic-Release Oral System Methylphenidate on Symptoms of Attention-Deficit Hyperactivity Disorder in Children and Adolescents
30. Lisdexamfetamine Dimesylate: A New Therapeutic Option for Attention-Deficit Hyperactivity Disorder
31. ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
32. Cortical blood flow during rest and Wisconsin Card Sorting Test performance in schizophrenia
33. The child and adolescent first-episode psychosis study (CAFEPS): Design and baseline results
34. Obstetrical complications in children at high risk for bipolar disorder
35. ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
36. Bipolar disorder in children and adolescents: international perspective on epidemiology and phenomenology
37. Antioxidant defense system and family environment in adolescents with family history of psychosis
38. Additional file 1: Table S1. of Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis
39. Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain : a descriptive analysis
40. ADHD Rating Scale–IV--Preschool Version; Spanish Version
41. Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) Mania and Rapid Cycling Sections
42. Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
43. Trastorno por déficit de atención e hiperactividad como factor de riesgo en intoxicaciones y lesiones no intencionales
44. Weight, Height, and Body Mass Index in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate.
45. RESTING-STATE FMRI CORRELATES OF CLINICAL RESPONSE TO STIMULANTS IN CHILDREN AND ADOLESCENTS WITH ADHD
46. 49.2 DIAGNOSTIC STABILITY AND TREATMENT RESPONSE OF BIPOLAR DISORDER IN A LONGITUDINAL FOLLOW-UP OF YOUTH IN SPAIN
47. The psychiatric diagnoses of twenty-two adolescents who have sexually molested other children
48. The European ADHD Guidelines Group replies
49. Normative ADHD-RS-Preschool Data in a Community Sample in Spain.
50. 2.42 Pharmacogenetic Predictors of Methylphenidate Response in Children and Adolescents With ADHD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.